SYDNEY (Reuters) - The Japanese yen edged higher on Friday as investors crept back in to the safe-haven currency on concerns that successful tests of a COVID-19 vaccine may not be enough to offset the economic damage of a trying winter in Europe and the United States.
The yen rose 0.2% to 104.89 per dollar in the Asia session, its highest since Monday when it tumbled after Pfizer announced that it had developed a working virus vaccine.
The yen remains down by about 1.5% against the dollar this week, its sharpest weekly drop in five months, and softer on most crosses. But the bounce from its lows - along with softness in riskier currencies - shows plenty of caution still remains.
The Aussie slipped 0.1% to $0.7224 and is headed for a small weekly loss. The kiwi was down 0.2% at $0.6824 though is headed for a weekly gain of 0.7% as investors reckon economic improvements have reduced the chance of negative rates.
The euro rose marginally overnight to clamber back over $1.18, but it is down about 0.6% for the week so far, helping the dollar index to a 0.7% weekly rise. The Chinese yuan was marginally weaker at 6.6219 per dollar.
Original Article:
Penafian: Pandangan yang dinyatakan adalah semata-mata dari pengarang dan tidak mewakili kedudukan rasmi Followme. Followme tidak bertanggungjawab ke atas ketepatan, kesempurnaan, atau kebolehpercayaan maklumat yang diberikan dan tidak bertanggungjawab untuk sebarang tindakan yang diambil berdasarkan kandungan, melainkan dinyatakan secara bertulis secara jelas.
Tiada komen lama, mula komen sekarang